Pages that link to "Q41325733"

The following pages link to Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. (Q41325733):

Displaying 29 items.

• Clinical Outlook for Type-1 and FOXP3( ) T Regulatory Cell-Based Therapy (Q26774657) (← links)
• Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells (Q28289781) (← links)
• Regulatory T cells and their roles in immune dysregulation and allergy. (Q34166571) (← links)
• In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells (Q34388925) (← links)
• HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia (Q34763454) (← links)
• The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases (Q35739662) (← links)
• Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4( ) T cells. (Q36220670) (← links)
• Regulatory T Cell Immunotherapy in Immune-Mediated Diseases (Q36462109) (← links)
• Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells (Q37535106) (← links)
• Dendritic cells in networks of immunological tolerance. (Q37826763) (← links)
• Clinical tolerance in allogeneic hematopoietic stem cell transplantation (Q37864697) (← links)
• Moving to tolerance: clinical application of T regulatory cells (Q37881151) (← links)
• Clinical perspectives for regulatory T cells in transplantation tolerance (Q37912653) (← links)
• The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells (Q38008355) (← links)
• Human tolerogenic DC-10: perspectives for clinical applications. (Q38078109) (← links)
• Potential and limitations of regulatory T-cell therapy in solid organ transplantation. (Q38235166) (← links)
• New insights into HLA-G mediated tolerance. (Q38240763) (← links)
• Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation (Q38640239) (← links)
• Regulatory T cell-based therapies for autoimmunity (Q38943933) (← links)
• Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression. (Q38949736) (← links)
• IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo (Q39076791) (← links)
• IL-10-Engineered Human CD4( ) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism. (Q40093839) (← links)
• HLA-G expression levels influence the tolerogenic activity of human DC-10. (Q41465101) (← links)
• Engineered T Regulatory Type 1 Cells for Clinical Application. (Q52678018) (← links)
• [Use of regulatory T cells in cellular therapies in autoimmune diseases]. (Q54492304) (← links)
• Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells. (Q55013923) (← links)
• APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells. (Q55260575) (← links)
• Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10) (Q64167471) (← links)
• Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation (Q92239193) (← links)